Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer-Reference-Cited by-同舟云学术

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer

Published:2018-05-11 Issue:36 Volume:9 Page:24457-24469
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shindo Tetsuya¹²,Niinuma Takeshi²,Nishiyama Naotaka¹,Shinkai Nobuo¹,Kitajima Hiroshi²,Kai Masahiro²,Maruyama Reo³,Tokino Takashi⁴,Masumori Naoya¹,Suzuki Hiromu²

Affiliation:

1. Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan

2. Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan

3. Project for Cancer Epigenome, The Cancer Institute, Japanese Foundation for Cancer, Koto-ku, Tokyo 135-8550, Japan

4. Medical Genome Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies;ChemistrySelect;2024-06-26

2. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06

3. The Role of Tumor‐Derived Extracellular Vesicles in Drug Resistance in Urologic Cancers;Advanced Therapeutics;2024-05-25

4. Histone acetylation: a key determinant of acquired cisplatin resistance in cancer;Clinical Epigenetics;2024-01-03

5. Effect of miR-200b Liposome Nanoparticles on Chemotherapy Resistance in Rats with Breast Cancer Through Induction of Epidermal Growth Factor Receptor/Extracellular Signal-Regulated Kinase Signal Pathway;Journal of Biomedical Nanotechnology;2023-12-01